Tuna oligopeptides ameliorate hyperuricemia and GA by reprogramming UA metabolic pathways, inhibiting NLRP3 inflammasome and TLR4/myeloid differentiation primary response 88/nuclear factor-kappa beta signaling pathway activation, and p65-nuclear factor-kappa beta phosphorylation. The gene discussed is TLR4; the disease is hyperuricemia.